Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Spotlight on Capecitabine in Colorectal Cancer

Spotlight on Capecitabine in Colorectal Cancer Capecitabine is an orally administered fluoropyrimidine which is selectively activated in tumor tissue to the active moiety fluorouracil and is cytotoxic through inhibition of DNA synthesis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Spotlight on Capecitabine in Colorectal Cancer

American Journal of Cancer , Volume 1 (2) – Aug 9, 2012

Loading next page...
 
/lp/springer-journals/spotlight-on-capecitabine-in-colorectal-cancer-7FTSa2UF06

References (23)

Publisher
Springer Journals
Copyright
Copyright © 2002 by Adis International Limited
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200201020-00007
Publisher site
See Article on Publisher Site

Abstract

Capecitabine is an orally administered fluoropyrimidine which is selectively activated in tumor tissue to the active moiety fluorouracil and is cytotoxic through inhibition of DNA synthesis.

Journal

American Journal of CancerSpringer Journals

Published: Aug 9, 2012

There are no references for this article.